ClinicalTrials.gg
Sign In
CompletedNCT04412928Updated Sep 15, 2023

Factors Affecting the Cure of Overactive Bladder Syndrome in Women Underwent Mid-urethral Sling Procedure

An observational study in Stress Urinary Incontinence, sponsored by Far Eastern Memorial Hospital. Completed at 1 site in Taiwan. Open to female participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2023-09-15.

Sponsored by Far Eastern Memorial Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
591
Ages
20 Years and older
Sex
Female
01

Study summary

We will estimate the incidence of patients with overactive bladder syndrome after surgery and explore related predictors.

Read the detailed description

At present, around 30% of women with stress urinary incontinence have overactive bladder syndrome after mid-urethral sling procedure. But its predictive factor is still unclear. We will estimate the incidence of patients with overactive bladder syndrome after surgery and explore related predictors. In addition, we will explore the cure rate and predictors of cure of overactive bladder syndrome after the mid-urethral sling procedure for women with stress urinary incontinence. The above results will be used as a reference for preoperative and postoperative consultation.

02

Conditions studied

  • Stress Urinary Incontinence
03

In context

Urinary Incontinence, Stress

671 studies on the registry are indexed under Urinary Incontinence, Stress; 122 are open to participants now.

This study's enrollment of 591 is above the median of 139 across 131 observational studies indexed under Urinary Incontinence, Stress.

Browse Urinary Incontinence, Stress studies →

Lead sponsor

Far Eastern Memorial Hospital is the lead sponsor of 259 studies on the registry; 39 are open to participants now.

Browse Far Eastern Memorial Hospital studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All women with stress urinary incontinence who underwent mid-urethral sling procedure.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All women with stress urinary incontinence who underwent mid-urethral sling procedure from January 01, 2008 to July 31, 2019 will be reviewed.

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing other gynecological operations at the same time, except for cystoscopy.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
591 participants (actual)
Patient registry
No

Interventions

  • Proceduremid-urethral sling procedure

    mid-urethral sling procedure

06

What researchers measure

Primary outcomes

  1. Factors affecting the presence of overactive bladder syndrome after mid-urethral sling procedure

    Time frame: 10 year

Secondary outcomes

  1. Factors affecting cure of overactive bladder syndrome after mid-urethral sling procedure

    Time frame: 10 years

07

Study locations

1 site
  • Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
    Banqiao District, New Taipei 22050, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2020 to primary completion in Mar 2021, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
May 31, 2020
First posted
Jun 2, 2020
StartActual
Apr 13, 2020
Primary completionActual
Mar 12, 2021
CompletionActual
Apr 20, 2021
Last update
Sep 15, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04412928
Lead sponsor
Far Eastern Memorial Hospital
Responsible party
Sheng-Mou Hsiao (Chief of Department of Obstetrics & Gynecology, Associate Professor, Far Eastern Memorial Hospital) — Principal investigator
First posted
Jun 2, 2020
Start date
Apr 13, 2020
Primary completion
Mar 12, 2021
Completion
Apr 20, 2021
Last update
Sep 15, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Urinary Incontinence, Stress →

Other studies from this sponsor

Far Eastern Memorial Hospital →

Start the discussion